<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alattar</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ibrahim</surname>
    <given-names>T. B. H.</given-names>
   </name>
   <name>
    <surname>Shaar</surname>
    <given-names>S. H.</given-names>
   </name>
   <name>
    <surname>Abdalla</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shukri</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Daghfal</surname>
    <given-names>J. N.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Tocilizumab for the treatment of severe coronavirus disease 2019.</article-title>
  <source>
   <italic>J. Med. Virol.</italic>
  </source> Online ahead of print. 
  <pub-id pub-id-type="doi">10.1002/jmv.25964</pub-id>
  <?supplied-pmid 32369191?>
  <pub-id pub-id-type="pmid">32369191</pub-id>
 </mixed-citation>
</ref>
